OTCMKTS:ELTP
Elite Pharmaceuticals Inc Stock News
$0.143
+0.0040 (+2.88%)
At Close: May 17, 2024
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information
04:55pm, Wednesday, 29'th Jun 2022
Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceut
Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022 NORTHVALE, NJ / ACCESSWIRE / June 23, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP),
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2022 Results - Earnings Call Transcript
02:11pm, Tuesday, 15'th Feb 2022
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2022 Results - Earnings Call Transcript
Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $8.97M
05:52am, Tuesday, 15'th Feb 2022 Seeking Alpha
Elite Pharmaceuticals press release (ELTP): FQ3 GAAP EPS of $0.00.Revenue of $8.97M (+48.3% Y/Y).10Q
Conference Call Scheduled for Tuesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty phar
Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Co
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q2 2022 Results - Earnings Call Transcript
04:45pm, Tuesday, 16'th Nov 2021
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q2 2022 Results - Earnings Call Transcript
Conference Call Scheduled for Tuesday, November 16th at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 15, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty ph
Financials for Second Quarter Fiscal Year 2022 Ended September 30, 2021 will be released November 15, 2021 NORTHVALE, NJ / ACCESSWIRE / November 9, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "
Elite Pharmaceuticals, Inc. (ELTP) CEO Narsat Hakim on Q1 2022 Results - Earnings Call Transcript
03:28pm, Tuesday, 17'th Aug 2021
Elite Pharmaceuticals, Inc. (ELTP) CEO Narsat Hakim on Q1 2022 Results - Earnings Call Transcript
Conference Call Scheduled for Tuesday, August 17 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company”) (OTCQB:ELTP), a specialty pharm
Financials for First Quarter Fiscal Year 2022 Ended June 30, 2021 will be released August 16, 2021 NORTHVALE, NJ / ACCESSWIRE / August 10, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")
Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2021 Results - Earnings Call Transcript
01:30pm, Tuesday, 15'th Jun 2021
Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2021 Results - Earnings Call Transcript
Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutic
